NOS3 and cystic fibrosis: Activation of eNOS has anti-inflammatory effects [7] and defective activation of eNOS through loss of cystic fibrosis transmembrane conductance regulator (CFTR) as a scaffold protein may contribute to endothelial inflammation in CF [8].